CEO Lee stated, D&D Pharmatech continues platform-based clinical expansion across two pillars: liver disease and CNS. He added, Histological results and additional biomarker data for DD01 will be released in the second quarter of this year. During the Q&A session after the presentation, a question was raised about DD01's strategic positioning, given that recently approved GLP-1 agonists for obesity treatment, such as Wegovy and Mounjaro, are now expanding into MASH indications
Immune System Function Ascorbic acid (vitamin C) acts as an antioxidant and plays a role in supporting normal immune responses
tGSH was calculated as the sum of reduced GSH and two times the amount of oxidized glutathione (tGSH = GSH + 2 GSSG)
This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors
Two to four sessions per week focusing on compound movements, squats, deadlifts, bench press, rows, overhead press, at moderate to heavy loads provides the muscle-preserving stimulus that makes the difference between losing primarily fat versus losing a mix of fat and muscle
348 Similarly, in human chondrocytes stimulated by TNF, GLP-1 analogs (such as liraglutide) showed an anti-catabolic effect, reducing the mRNA expression of MMP-3, MMP-13, and ADAMTS5